2-(6-chloro-1H-indazol-1-yl)acetic acid

ID: ALA4095901

PubChem CID: 13337779

Max Phase: Preclinical

Molecular Formula: C9H7ClN2O2

Molecular Weight: 210.62

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)Cn1ncc2ccc(Cl)cc21

Standard InChI:  InChI=1S/C9H7ClN2O2/c10-7-2-1-6-4-11-12(5-9(13)14)8(6)3-7/h1-4H,5H2,(H,13,14)

Standard InChI Key:  SLRWYLOBERUSHR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 14 15  0  0  0  0  0  0  0  0999 V2000
   16.7236   -1.7241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7225   -2.5511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4369   -2.9637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4351   -1.3116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1502   -1.7204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1550   -2.5511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9465   -2.8032    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4309   -2.1283    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9387   -1.4592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2059   -3.5859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6577   -4.2019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0081   -2.9628    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   17.8501   -4.0352    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.9171   -4.9846    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  7 10  1  0
 10 11  1  0
  2 12  1  0
 11 13  2  0
 11 14  1  0
M  END

Alternative Forms

Associated Targets(Human)

KMO Tchem Kynurenine 3-monooxygenase (379 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 210.62Molecular Weight (Monoisotopic): 210.0196AlogP: 1.77#Rotatable Bonds: 2
Polar Surface Area: 55.12Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.51CX Basic pKa: 1.39CX LogP: 1.50CX LogD: -1.87
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.82Np Likeness Score: -1.99

References

1. Liddle J, Beaufils B, Binnie M, Bouillot A, Denis AA, Hann MM, Haslam CP, Holmes DS, Hutchinson JP, Kranz M, McBride A, Mirguet O, Mole DJ, Mowat CG, Pal S, Rowland P, Trottet L, Uings IJ, Walker AL, Webster SP..  (2017)  The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis.,  27  (9): [PMID:28336141] [10.1016/j.bmcl.2017.02.078]

Source